arrow
M

Matthias Gückenberger

University of Zurich
H指数:87
被引数:3.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mind the data: pitfalls and perspectives in acquiring and interpreting preclinical evidence for the FLASH effect

注意数据:获取和解释FLASH效应预临床证据的陷阱与展望

2026-10-240
PRE
Early target volume dynamics during MR-guided radiotherapy for glioblastoma: first results from the prospective MARGA-I trial

MR引导放射治疗胶质母细胞瘤早期靶区体积动态变化:前瞻性MARGA-I试验的初步结果

2026-10-040
OA
LINACS: an ESTRO/OligoCare living systematic review of the safety of concurrent stereotactic radiotherapy and novel systemic therapies (version 1)

LINACS:一项ESTRO/OligoCare实时系统综述,评估同步立体定向放疗和新型全身治疗的安全性(版本1)

2026-09-230
PRE
The impact of national health systems on lung cancer mortality

国家卫生系统对肺癌死亡率的影响

Chest
IF8.6
2026-08-290
PRE
TPRG-04 ETOP 19-21 USZ-STRIKE: IMMUNOTHERAPY OR TARGETED THERAPY WITH OR WITHOUT STEREOTACTIC RADIOSURGERY FOR PATIENTS WITH BRAIN METASTASES FROM MELANOMA OR NON-SMALL CELL LUNG CANCER

TPRG-04 ETOP 19-21 USZ-STRIKE:针对黑色素瘤或非小细胞肺癌脑转移患者的免疫治疗或靶向治疗,联合或不联合立体定向放射外科

2026-08-070
OA
PSA persistence in the PSMA PET era: reassessing a risk factor after radical prostatectomy

PSA在PSMA PET时代的持续性:根治性前列腺切除术后重新评估风险因素

2026-06-130
OAAI
Leveraging the potential of prospective registries for radiation oncology research: 5-year experience from the EORTC-ESTRO radiotherapy infrastructure for Europe (E2-RADIatE) project

利用前瞻性登记研究的潜力进行放射肿瘤学研究:欧洲放射治疗基础设施EORTC-ESTRO项目(E2-RADIatE)5年经验

2026-06-060
PRE
Personalized volume de-escalated elective nodal irradiation in oropharyngeal squamous cell carcinoma (DeEscO): a study protocol

基于DeEscO研究的口咽鳞状细胞癌个体化缩边选择性淋巴结照射方案研究

2026-05-120
OA
Stereotactic body radiotherapy for locally advanced pancreatic adenocarcinoma: a systematic review and meta-analysis of prospective trials

立体定向体部放射治疗局部晚期胰腺腺癌:前瞻性试验的系统评价和荟萃分析

2026-05-060
PRE
Clinical radiation audits as a tool for the optimization of radiation exposure in cardiac electrophysiology procedures

临床辐射审计作为优化心脏电生理操作中辐射暴露的工具

2026-05-011
OA
Doughnut-shaped bone lesions on 18F-FDG-PET/CT may indicate pseudoprogression under immuno(radio)therapy

18F-FDG-PET/CT上环形骨病灶可能提示免疫(放射)疗法下的假性进展

2026-02-120
PRE
The prospective phase I “Flash-Skin I” trial: ultra-high dose rate radiotherapy implementation and quality assurance at a clinical linear accelerator

前瞻性I期“Flash-Skin I”试验:超高剂量率放射治疗在临床直线加速器上的实施与质量保证

2026-01-090
PRE
Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: Long-term Data from the SAKK 09/10 Randomised Phase 3 Trial

剂量强化与常规剂量挽救性放疗治疗前列腺切除术后生物化学复发性前列腺癌:SAKK 09/10随机III期试验的长期数据

2026-01-050
OAAI
Interdisciplinary Swiss consensus recommendations for follow-up after radical cystectomy and trimodal treatment for muscle-invasive bladder cancer

多学科瑞士共识:肌层浸润性膀胱癌根治性膀胱切除及三联治疗后随访建议

2026-01-010
PRE